Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasal Patency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06301035
What this trial is testing

Asymmetric High-flow Nasal Cannula (HFNC) vs Standard HFNC for Post Extubation High-risk Group

Who this might be right for
Acute Respiratory Failure
Samsung Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03603678
What this trial is testing

Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor

Who this might be right for
Sleep Apnea, Obstructive
Bayer 34
Large-scale testing (Phase 3)Study completedNCT02402933
What this trial is testing

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

Who this might be right for
HypoglycemiaDiabetes Mellitus
Eli Lilly and Company 26
Large-scale testing (Phase 3)UnknownNCT02085655
What this trial is testing

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Huiqiang Huang 264
Large-scale testing (Phase 3)Study completedNCT02782104
What this trial is testing

A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
Janssen Research & Development, LLC 1,148
Testing effectiveness (Phase 2)Ended earlyNCT03769467
What this trial is testing

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsEpstein-Barr Virus Infections+2 more
Atara Biotherapeutics 12
Large-scale testing (Phase 3)Study completedNCT00735527
What this trial is testing

Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children

Who this might be right for
Status EpilepticusSeizures
All India Institute of Medical Sciences 140
Not applicableStudy completedNCT06233188
What this trial is testing

Effect of Customized Lateral Nasal Wall Osteotomy on the Pterygomaxillary Separation During le Fort I Down-fracture

Who this might be right for
MalocclusionOpen BiteLe Fort; I+1 more
Bezmialem Vakif University 43
Early research (Phase 1)Study completedNCT03401346
What this trial is testing

Bioavailability of DHE Administered by I123 POD Device, IV Injection, and Migranal Nasal Spray in Healthy Adults

Who this might be right for
Migraine Headache
Impel Pharmaceuticals 36
Early research (Phase 1)Study completedNCT02598856
What this trial is testing

Bioavailability of Nasal Naloxone and Injected Naloxone Compared

Who this might be right for
Drug Overdose
Norwegian University of Science and Technology 22
Early research (Phase 1)Study completedNCT01194622
What this trial is testing

Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal Sprays

Who this might be right for
Allergic Rhinitis
MEDA Pharma GmbH & Co. KG 30
Not applicableStudy completedNCT05999955
What this trial is testing

Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis

Who this might be right for
RhinosinusitisRhinitis
Huro Biotech Joint Stock Company 60
Not applicableStudy completedNCT01001130
What this trial is testing

Regulatory AVAMYS Nasal Spray PMS

Who this might be right for
Rhinitis, Allergic, Perennial and Seasonal
GlaxoSmithKline 3,244
Early research (Phase 1)Looking for participantsNCT07726147
What this trial is testing

Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the Safety, Tolerability and Preliminary Immunogenicity of ITI-9001 in Japanese Patients With Japanese Red Cedar (JRC) Pollinosis

Who this might be right for
Allergen Immunotherapy
Immunomic Therapeutics, Inc. 45
Not applicableStudy completedNCT03127436
What this trial is testing

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Who this might be right for
Perennial Allergic Rhinitis
University Hospital of Cologne 32
Not applicableStudy completedNCT01967732
What this trial is testing

Nicotine Pharmacokinetic Profile and Safety of the Tobacco Heating System 2.2 (THS 2.2)

Who this might be right for
Smoking
Philip Morris Products S.A. 62
Early research (Phase 1)Ended earlyNCT05887843
What this trial is testing

Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Sandoz 38
Not applicableNot Yet RecruitingNCT07750613
What this trial is testing

Time Course of Respiratory Oscillometry Parameters During Nasal High-Flow Therapy in Stable Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
ADIR Association 20
Large-scale testing (Phase 3)Study completedNCT02401191
What this trial is testing

A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic Rhinitis

Who this might be right for
Rhinitis Allergic
Sanofi 105
Testing effectiveness (Phase 2)Looking for participantsNCT05475925
What this trial is testing

DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Who this might be right for
LGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell LymphomaPrimary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma+10 more
Dren Bio 200
Next Page